Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

February 2020 Vol 6 No 1

First-Line Calquence-Based Combination Therapy for Patients with Chronic Lymphocytic Leukemia
Calquence, a new-generation targeted therapy recently approved for the treatment of CLL, has shown good results in a 3-drug combination therapy. Read More ›

Addressing the Negative Associations with Lung Cancer
Dr. Joan Schiller, like many cancer care advocates, is working to change the negative attitudes and misconceptions about lung cancer, which is often seen as being caused by the patient, but in reality affects many people who never have smoked. Read More ›

Staging of Non–Small-Cell Lung Cancer: A Guide for Patients
Knowing the stage of lung cancer helps oncologists to plan the best treatment plan for each patient. This first article in the series explains how the most common type of lung cancer is staged. Read More ›

First Love Yourself: Picking Up the Pieces
When 24-year-old Mia Brister was diagnosed with Hodgkin lymphoma, it was as if her whole world had shattered. She had to learn to be kind with herself to put her life together again. Read More ›

Nature Photography Is Healing My Spirit
After being diagnosed with a genetic mutation associated with immune disorders, including myelodysplastic syndromes and leukemia, Marit Chrislock had to give up her long-distance running in the Colorado mountains, using photography to express her love of nature. Read More ›

The Rite of Passage
Within the oncology world, there is a new controversy thick in the air—"Ringing of the bell." Read More ›

Healthy Food Habits for Colon Cancer Risk Reduction and Survivorship
Oncology dietitian Julie Lanford offers tips on how to reduce the risk of colon cancer, as well as strategies for survivors during and after cancer treatment. Read More ›

New All-Oral Combination Therapy for CLL Shows Impressive Results
A new study using a combination of the 2 oral drugs, Copiktra and Venclexta, showed promising results for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma. Read More ›

Brukinsa, a New BTK Inhibitor, Shows Impressive Results in Patients with CLL
Brukinsa, which was approved for use in patients with mantle-cell leukemia in late 2019, has also showed promising results in 2 recent clinical trials of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), including patients with high-risk genetic abnormalities. Read More ›

From Fly-Fishing to “Ringing the Bell”
Hello everyone and welcome to our February 2020 issue of CONQUER: the patient voice! Once again, we have packed many articles into this new issue to empower you with information, provide hope through inspirational stories from others, and perhaps help you look at the world with a different perspective. Read More ›

Page 1 of 2